Jaguar Health (JAGX) Other Working Capital Changes (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Other Working Capital Changes of -$42000.0 for Q1 2026, up 2.33% year-over-year from -$41045.5 in Q1 2025, and up 2.33% quarter-over-quarter from -$43000.0 in Q4 2025.
Jaguar Health (JAGX) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Other Working Capital Changes for 4 consecutive years, with -$42000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 2.33% year-over-year to -$42000.0; the TTM figure through Mar 2026 stood at -$170000.0 (changed 0.0% YoY), while the FY2025 annual figure was -$171000.0, down 123.65% from the prior year.
- Other Working Capital Changes grew to -$42000.0 in Q1 2026 per JAGX's latest filing, from -$43000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.8 million in Q2 2023 and bottomed at -$3.0 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$87117.6 across 5 years, with a median of -$53000.0 in 2023.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes tumbled 105.06% — and 2026, when it grew 2.33%.
- Jaguar Health's Other Working Capital Changes stood at -$42000.0 in 2024, then declined by 2.38% to -$43000.0 in 2025, then grew by 2.33% to -$42000.0 in 2026.
- Business Quant data shows JAGX's Other Working Capital Changes at -$42000.0 in Q1 2026, -$43000.0 in Q4 2025, and -$43000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - |
| 10 | Jaguar Health | 458,638.68 | -9.61 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49,000.00 |
| Mar 31, 2026 | -49,000.00 |
| Mar 31, 2026 | -49,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | 996,000.00 |
| Sep 30, 2025 | 996,000.00 |
| Sep 30, 2025 | 996,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Dec 31, 2024 | -2.15 Mn |
| Dec 31, 2024 | -2.15 Mn |
| Dec 31, 2024 | -2.15 Mn |
| Sep 30, 2024 | -962,000.00 |
| Sep 30, 2024 | -962,000.00 |